SlideShare a Scribd company logo
MYOCARDIAL PROTECTION
BY DR NIKUNJ
(CTS RESIDENT STAR HOSPITAL)
(Coordinator:DR P.SATYENDRANATH PATHURI)
(22/10/18)
HISTORICAL DEVELOPMENT
• After the initiation of open heart surgery with use of extra- corporeal circulation by
Gibbon, it soon became obvious that aortic cross-clamping was necessary to
provide a bloodless field to facilitate the precise repair of intracardiac defects, to
prevent air embolism when the left side of the heart was opened, and to avoid a
turgid myocardium resistant to retraction.
• To overcome the difficulties of operating on a rheumatic mitral valve in a patient
with aortic regurgitation, Melrose and colleagues introduced the concept of
“elective cardiac arrest” by rapidly injecting into the aortic root, after aortic cross-
clamping, a 2.5% potassium citrate solution in warm blood to arrest the heart.
• myocardial necrosis associated with the Melrose technique.
MYOCARDIAL PROTECTION
• Involves strategies and methods used to reduce or prevent post-ischemic
myocardial dysfunction during and after heart surgery.
NON-CARDIOPLEGIC TECHNIQUES
FIBRILLATORY ARREST
• Electrically induced ventricular brillation with coronary perfusion was introduced
by Glenn and Sewell and Senning as a means of avoiding air embolism.
• subendocardial ischemia and necrosis with this technique.
• Not applicable for intracardiac procedures
• Field may be obscured by blood during revascularization
• Ventricular fibrillation is associated with increased muscular tone (can limit
surgeon’s ability to position the heart for optimal exposure)
CONTINUOUS CORONARY PERFUSION
• In an attempt to mimic the physiologic state, continuous coronary perfusion with a
beating heart at normothermia or mild hypothermia at 32°C to prevent the onset
of ventricular fibrillation became the preferred technique of myocardial
preservation in the late 1960s and early 1970s,
• particularly after the report by McGoon and colleagues17 of 100 consecutive
aortic valve replacements with no deaths.
• continuous perfusion became intermittent as coronary perfusion was often
discontinued to achieve better visualization of the operative field during critical
portions of the procedure.
• In addition, problems with the coronary cannula, such as poor fixation, leaking
associated with calcified ostia, early division of the left main coronary artery
resulting in high perfusion pressure necrosis, and damage to the coronary artery
such as dissection and late stenosis, continued to occur.
HYPOTHERMIA
• The earliest attempts to perform open heart surgery before the advent of the heart-
lung machine used systemic hypothermia produced by surface cooling not only to
protect the heart but to protect the brain and other organs during circulatory arrest
• Hypothermia protects the ischemic myocardium by decreasing heart rate, slows the
rate of high-energy phosphate degradation,24 and decreases myocardial oxygen
consumption .
• concept of profound local (topical) hypothermia by filling the pericardial sac with ice-
cold saline.
• this technique is still used as an adjunct to other methods of myocardial protection, it is
rarely used as the sole protec- tive method because of the problem of warm bronchia
collateral flow reaching the heart cavity, resulting in transmyocardial temperature
gradients and resultant ischemia.
•
• Hypothermia and potassium infusions remain cornerstone of myocardial
protection during on- pump heart surgery
• Other cardioprotective techniques and methods are available.
•
• Ideal cardioprotective technique, solution, and method of administration have yet
to be found
BIOLOGY OF SURGICALLY INDUCED MYOCARDIAL ISCHEMIA
• Myocardial Oxygen Consumption :
• Myocardial oxygen reserve is exhausted within 8 seconds after the onset
of normothermic global ischemia.
• Myocardial oxygen consumption ( MVO2) is compartmentalized into the
oxygen needed for external work of contraction (80% to 90%) and the
unloaded contraction, such as basal metabolism, excitation-contraction
coupling, and heat production.
• A unique aspect of myocardial energetics is that 75% of the coronary
arterial oxygen presented to the myocardium is extracted during a single
passage through the heart;
BIOLOGY OF SURGICALLY INDUCED MYOCARDIAL ISCHEMIA
• Biochemical Alterations:
• Under aerobic conditions, the heart derives its energy primarily from
mitochondrial oxidative processes, using substrates such as glucose, free
fatty acids, lactate, pyruvate, acetate, ketone bodies, and amino acids.
However, oxidation of fatty acids provides the major source of energy
production and is used in preference to carbohydrates.
• as tissue PO2 falls, oxidative phosphorylation, electron transport, and
mitochondrial adenosine triphosphate (ATP) production cease.
• Reduced mitochondrial activity leads to the accumulation of glycolytic
intermediaries, reduced NADH, and the reduction of pyruvate to lactate.
The resultant severe intracellular acidosis impairs contractile function,
enzyme transport, and cell membrane integrity.
• This results in a cellular loss of potassium and pathologic accumulation of
sodium, calcium, and water
ISCHEMIA-REPERFUSION INJURY
CALCIUM HYPOTHESIS
• Inability of myocyte to modulate
intracellular and intraorganellar calcium
homeostasis.
•
• Cascade of events culminating in cell
injury and death is induced .
• Calcium.
• if given as patients come off of bypass,
it can lead to contracture of heart
(maximally contracted heart)
• Therefore, it is desirable to avoid
calcium when heart is recovering from
arrest
FREE RADICAL
HYPOTHESIS
• Accumulation of reactive oxygen
species (ROS) – during early stages
of reperfusion – causes myocardial
cellular damage and cell death
through microscomal peroxidation
of cellular phospholipid layer
• Leads to loss of cellular integrity
and function
• Stunning: “describes the mechanical dysfunction that persists after reperfusion
despite the absence of myocellular damage and despite the return of normal or
nearnormal perfusion.”
• Hibernation:, which is a syndrome of reversible, chronically reduced contractile
function as a result of one or more recurrent episodes of acute or persistent
ischemia, referred to as chronic stunning
IRREVERSIBLE CELL INJURY
• necrosis and apoptosis.
• Necrosis is initiated by noncellular mechanisms with cell swelling, depletion of
ATP stores, and disruption of the cellular membrane involving uid and electrolyte
alterations.
• In contrast, apoptosis (programmed cell death) is an evolution-based mode of cell
death characterized by a discrete set of biochemical and morphologic events
involving the regulated action of catabolic enzymes (proteases and nucleases) that
results in the ordered disassembly of the cell, distinct from cell death provoked by
external injury.
ISCHEMIA-REPERFUSION INJURY
• INFLAMMATION
• In ammation has been implicated as a secondary mecha- nism contributing to
injury after reperfusion. It is initi- ated through complement activation leading to
the sequential formation of a membrane attack complex, which creates a cellular
lesion and eventual cell lysis.
• EFFECTS OF AGE
• The vulnerability of the heart to ischemia-reperfusion injury is altered with
temporal development. The newborn heart is more resistant to the effects of
ischemia- reperfusion.
• in the adult heart, functional recovery is significantly delayed
• CYANOSIS
• Cyanosis signi cantly increases the vulnerability of the myocardium to ischemia-
reperfusion injury.
• VENTRICULAR HYPERTROPHY
• Hypertrophied hearts have an increased vulnerability to ischemic injury
• All patients undergoing cardiac surgery have varying degrees of myocardial
stunning
• Evidence:
• Requirement of inotropic support for separation from bypass
• Support may last from hours to days after surgery
• Patients are eventually weaned from these drugs as the stunning abates, without
objective evidence of MI
CARDIOPLEGIA: BASIC PRINCIPLES
• (1) rapid induction of arrest,
• (2) mild or moderate hypothermia,
• (3) appropriate buffering of the cardioplegic solution,
• (4) avoidance of myocardial edema, and
• (5) avoidance of substrate depletion.
(1) RAPID INDUCTION OF ARREST
• Rapid cardiac arrest remains the mainstay of adequate myocardial protection and
is “achieved by targeting various points in the excitation-contraction coupling
pathway”
DEPOLARIZED ARREST
• Potassium is the most common agent used for chemical cardioplegia and produces
rapid diastolic arrest.
• As the extracellular potassium concentration increases, the resting myocardial cell
membrane becomes depolarized; the voltage-dependent fast sodium channel is
inactivated, arresting the heart in diastole; and the slow calcium channel is
activated, resulting in cytosolic calcium overload
• The optimum concentration of potassium is thought to vary between 15 and 40
mmol/liter although it has been suggested that concentrations exceeding 20
mmol/liter promote calcium overload and subsequent injury.
• Because the heart will remain arrested until the concentration of extracellular
potassium or other cardioplegic ingredient is decreased by noncoronary collateral
mediastinal blood flow, reinfusions of cardioplegia are necessary every 15 to 30
minutes
•
POLARIZED ARREST
• Agents inducing polarized arrest, in which the cell membrane potential remains
close to resting potential, have significant advantages by limiting ionic movement
and thereby reducing myocardial energy use
• Sodium channel blockade, which arrests the heart by preventing the rapid sodium-
induced depolarization of the action potential, includes procaine and tetrodotoxin.
This class of drugs has been used successfully experimentally but is rarely used
clinically at present.
• Potassium channel openers induce arrest by membrane hyperpolarization, couple
the membrane potential to the cellular metabolic status, and afford
cardioprotection by a similar mechanism associated with ischemic
preconditioning.
• their clinical use remains controversial.
• Adenosine is an endogenous nucleoside
• Extracellular adenosine is cleared through cellular uptake, primarily by
erythrocytes and vascular endothelial cells, and has a reported half-life of less than
10 seconds in whole blood, which limits its use during a prolonged period of
surgically induced ischemia.
• Adenosine induces hyperpolarized cardiac arrest by antagonizing calcium channels
and has been shown to inhibit both the sinoatrial and the atrioventricular nodes
and atrial myocardial contraction.
• Adenosine, by its ability to antagonize the direct depressant effects on both the
sinoatrial and atrioventricular nodes and atrial tissue, results in sinus slowing and
arrest.
HYPOTHERMIA
• Hypothermia, whether it is mild (tepid at the room temperature range of 28° C to
32° C) or moderate (22° C to 25°C), continues to remain an indispensable adjunct
for adequate myocardial protection.
• hypothermia decreases the rate of the metabolic degradation of energy stores
during surgically induced ischemia.
• However, there is minimal advantage in reducing the myocardial temperature
below 22° C, because the MVO2 is decreased by only a minimal amount, from 0.31
mL at 22°C to 0.27 mL at 15°C per 100 g of left ventricular tissue per minute
BUFFERING OF THE CARDIOPLEGIC SOLUTION
• Buffering of the cardioplegic solution is necessary to combat the
unremitting intracellular acidosis associated with surgically induced
myocardial ischemia.
• Because the myocardium has the highest oxygen use of any organ in the
body related to its concentration of mitochondria, ischemia results in the
rapid accumulation of hydrogen ions and the reduction of intracellular pH
• here is clinical evidence that maintenance of the tissue pH of 6.8 or
greater is associated with adequate myocardial protection
• In addition, hypothermia assists in the neutralization of acidosis because
pH rises 0.0134 unit for each decrease in degree centigrade.
• Bicarbonate, phosphate, aminosulfonic acid,
tris(hydroxymethyl)aminomethane (THAM), and histidine buffers have all
been used as cardioplegia additives to modulate pH.
AVOIDANCE OF MYOCARDIAL EDEMA
• Avoidance of myocardial edema by controlling osmolarity is important to control
volume regulation of the fluid compartments of the heart because myocardial
edema is a known consequence of ischemia.
• The extent of myocardial edema has been shown to be directly modulated by
osmolarity and onconicity of cardioplegia, with decreases being directly associated
with increased myocardial edema and impaired diastolic filling.
• The extent of myocardial edema has been shown to be directly modulated by
osmolarity and onconicity of cardioplegia, with decreases being directly associated
with increased myocardial edema and impaired diastolic filling.
• In addition to cardioplegic infusions, the hemodilution from crystalloid priming of
the extracorporeal circuit, the activation of humoral and cellular mediators that
increase microvascular permeability, and the impairment of myocardial lymphatic
function may play major roles in the development of myocardial edema.
• Myocardial lymphatic function is dependent on the beating heart to transport
fluid and is significantly reduced or completely stopped during cardiac arrest.
CRYSTALLOID CARDIOPLEGIA
• With the advent of myocardial protection, asanguineous solutions
composed of varying electrolyte compositions, but always featuring
hyperkalemic diastolic arrest, were clinically used in Europe in the early
1970s and in the United States in the late 1970s.
• However, these solutions contained minimal amounts of dissolved oxygen,
whereas the myocardium consumes 0.33 mL of oxygen per 100 g at 15° C.
Because even a short period of ischemia results in the gradual
accumulation of oxygen debt, moderate to severe myocardial hypothermia
is necessary to prevent the rapid degradation of energy stores
CRYSTALLOID CARDIOPLEGIA
• Patients are first placed on CPB
• Cooled to between 28-33 °C
• Soln infused after cross-clamping aorta through cardioplegic catheter inserted into
aorta proximal to cross-clamp
BLOOD CARDIOPLEGIA
• In an attempt to avoid the oxygen deficits associated with crystalloid
cardioplegia, blood was introduced as a Suitable vehicle to obtain
optimum oxygenation.
• Experimentally, blood cardioplegia has been demonstrated to be superior
to oxygenated crystalloid cardioplegia.
• the physiologic advantages of blood include the buffering and reducing
capacity, the presence of colloid to avoid adverse oncotic pressure
gradients, and the presence of oxygen free radical scavengers
• The early blood cardioplegia solutions used a ratio of four parts blood to
one part crystalloid (4 : 1)
• Del Nido cardioplegia techniques The cardioplegia solution is administered
as a single dose, using dilute blood in a 1 : 4 ratio,
METHODOLOGIES
warm blood cardioplegia
• Warm heart surgery assumes that aerobic arrest, whereby the heart is
electromechanically arrested and continuously perfused with warm blood
cardioplegia, is the ideal statefor the performance of safe cardiac surgery.
• ADVANTAGES of this technique include
• the presumed elimination of anaerobic ischemic injury with cross-clamp times
safely extended up to 6.5 hours;
• the early resumption of a normal sinus rhythm after removal of the aortic clamp;
• the avoidance of a prolonged rewarming and reperfusion time, thus decreasing
total bypass time; and the elimination of systemic hypothermia and associated
vasoconstriction in the early postoperative period.
• PROBLEMS :
• However, difficulties in visualization of the operative field, particularly in
performing distal coronary anastomoses, mandated temporary discontinuation of
the warm cardioplegic infusion,
COLD BLOOD CARDIOPLEGIA
• Prepared by combining autologous blood from extracorporeal circuit (while
patient is on CPB) with a crystalloid soln of:
• citrate-phosphate-dextrose (CPD)  lowers ionic calcium
• tris-hydroxymethyl-aminomethane (tham) or bicarbonate buffersmaintains
alkaline pH of ~7.8
• potassium chloride  arrests heart at 30 mmol/L
• pH = 7.4 is physiologic, but pH is temp dependent, and optimal buffering occurs
when pKa is 7.8.
COLD BLOOD CARDIOPLEGIA
• Reasons to use blood for hypothermic potassium-induced cardiac arrest:
• Provides oxygenated environment
• Provides method for intermittent reoxygenation of heart during arrest
• Can limit hemodilution when large volumes of cardioplegia are used
• Has excellent buffering capacity
• Has excellent osmotic properties
• The electrolyte composition and pH are physiologic
• Contains endogenous antioxidants and free-radical scavengers
• Is less complex than other solns to prepare
TEPID (29°C) CARDIOPLEGIA
• introduced as a means of overcoming the deficits of warm cardioplegia, without
the adverse effects of cold cardioplegia.
• Both cold blood and warm blood solns have temperature related advantages and
disadvantages
METHODS OF DELIVERY
• Methods of Delivery ;
• INTERMITTENT ANTEGRADE
• ANTEGRADE VIA THE CORONARY
BYPASS GRAFTS
• CONTINUOUS ANTEGRADE
• CONTINUOUS RETROGRADE
• INTERMITTENT RETROGRADE
• ANTEGRADE FOLLOWED BY
RETROGRADE
• SIMULTANEOUS ANTEGRADE AND
RETROGRADE
RETROGRADE PERFUSION
• 1965 – Lillehei et al. Dis Chest.
• Reported use of retrograde perfusion to protect
heart during aortic valve surgery
• ADVANTAGE of ensuring a more homogeneous
distribution of cardioplegic soln to regions of heart
that are poorly collateralized
• Effective in setting of AR and valve surgery
• Effective in reducing risk of embolization from
SVGs that could occur during antegrade perfusion
during re-op CABG
• Effective in delivering cardioplegia in continuous
manner
• LIMITATIONS:
• Soln can be poorly distributed to the right ventricle
due to the variable venous anatomy of the heart
• Best and most continuous perfusion of the anterior
left and right ventricles is achieved using antegrade
and retrograde routes simultaneously
Thank you

More Related Content

What's hot

Hypothermia, DHCA, RCP, ACP,Oxygen consumption,Cooling, Rewarming.
Hypothermia, DHCA, RCP, ACP,Oxygen consumption,Cooling, Rewarming.Hypothermia, DHCA, RCP, ACP,Oxygen consumption,Cooling, Rewarming.
Hypothermia, DHCA, RCP, ACP,Oxygen consumption,Cooling, Rewarming.
karthi murugan
 
Deep hypothermic circulatory arrest in pediatric cardiac sur
Deep hypothermic circulatory arrest in pediatric cardiac surDeep hypothermic circulatory arrest in pediatric cardiac sur
Deep hypothermic circulatory arrest in pediatric cardiac sur
Manu Jacob
 
Ultrafiltration during cardiopulmonary_bypass
Ultrafiltration during cardiopulmonary_bypassUltrafiltration during cardiopulmonary_bypass
Ultrafiltration during cardiopulmonary_bypass
dr amarja nagre
 
DHCA
DHCA DHCA
DHCA
Manu Jacob
 
7 Adequacy Of Perfusion During Cardiopulmonary Bypass
7 Adequacy Of Perfusion During Cardiopulmonary Bypass7 Adequacy Of Perfusion During Cardiopulmonary Bypass
7 Adequacy Of Perfusion During Cardiopulmonary BypassDang Thanh Tuan
 
Complications and safety during cpb
Complications and safety during cpbComplications and safety during cpb
Complications and safety during cpb
Manu Jacob
 
Cardioplegia and surgical ischemia
Cardioplegia and surgical ischemiaCardioplegia and surgical ischemia
Cardioplegia and surgical ischemia
Peter Flash
 
Microemboli gaseous and particulate
Microemboli gaseous and particulateMicroemboli gaseous and particulate
Microemboli gaseous and particulate
Manu Jacob
 
Priming and Hemodilution
Priming and HemodilutionPriming and Hemodilution
Priming and Hemodilution
Muhammad Badrushshalih
 
ALPHA STAT & PH STAT.pptx
ALPHA STAT & PH STAT.pptxALPHA STAT & PH STAT.pptx
ALPHA STAT & PH STAT.pptx
ssuserb836a1
 
Cardioplegia
CardioplegiaCardioplegia
Cardioplegia
Raja Lahiri
 
CPB during pregnancy and Anesthesia considration by Arsalan
CPB during pregnancy and Anesthesia considration by ArsalanCPB during pregnancy and Anesthesia considration by Arsalan
CPB during pregnancy and Anesthesia considration by Arsalan
Arsalan Khan
 
Cardiopulmonary bypass effect to others organs
Cardiopulmonary bypass effect to others organsCardiopulmonary bypass effect to others organs
Cardiopulmonary bypass effect to others organsIda Simanjuntak
 
Hypothermia and dhca
Hypothermia and dhcaHypothermia and dhca
Hypothermia and dhca
drabhimishra83
 
MICS
MICSMICS
Myocardial Protection in Pediatric Cardiac Surgery
Myocardial Protection in Pediatric Cardiac SurgeryMyocardial Protection in Pediatric Cardiac Surgery
Myocardial Protection in Pediatric Cardiac Surgery
Slide Sharer
 
Priming fluid and hemodilution
Priming fluid and hemodilutionPriming fluid and hemodilution
Priming fluid and hemodilution
Manu Jacob
 
cannulation techniques during cpb
cannulation techniques during cpbcannulation techniques during cpb
cannulation techniques during cpb
Manu Jacob
 
Immune system and inflamatory response to cpb(1)
Immune system and inflamatory response to cpb(1)Immune system and inflamatory response to cpb(1)
Immune system and inflamatory response to cpb(1)
Manu Jacob
 
Cardiopulmonary bypass
Cardiopulmonary bypassCardiopulmonary bypass
Cardiopulmonary bypass
Alireza Kashani
 

What's hot (20)

Hypothermia, DHCA, RCP, ACP,Oxygen consumption,Cooling, Rewarming.
Hypothermia, DHCA, RCP, ACP,Oxygen consumption,Cooling, Rewarming.Hypothermia, DHCA, RCP, ACP,Oxygen consumption,Cooling, Rewarming.
Hypothermia, DHCA, RCP, ACP,Oxygen consumption,Cooling, Rewarming.
 
Deep hypothermic circulatory arrest in pediatric cardiac sur
Deep hypothermic circulatory arrest in pediatric cardiac surDeep hypothermic circulatory arrest in pediatric cardiac sur
Deep hypothermic circulatory arrest in pediatric cardiac sur
 
Ultrafiltration during cardiopulmonary_bypass
Ultrafiltration during cardiopulmonary_bypassUltrafiltration during cardiopulmonary_bypass
Ultrafiltration during cardiopulmonary_bypass
 
DHCA
DHCA DHCA
DHCA
 
7 Adequacy Of Perfusion During Cardiopulmonary Bypass
7 Adequacy Of Perfusion During Cardiopulmonary Bypass7 Adequacy Of Perfusion During Cardiopulmonary Bypass
7 Adequacy Of Perfusion During Cardiopulmonary Bypass
 
Complications and safety during cpb
Complications and safety during cpbComplications and safety during cpb
Complications and safety during cpb
 
Cardioplegia and surgical ischemia
Cardioplegia and surgical ischemiaCardioplegia and surgical ischemia
Cardioplegia and surgical ischemia
 
Microemboli gaseous and particulate
Microemboli gaseous and particulateMicroemboli gaseous and particulate
Microemboli gaseous and particulate
 
Priming and Hemodilution
Priming and HemodilutionPriming and Hemodilution
Priming and Hemodilution
 
ALPHA STAT & PH STAT.pptx
ALPHA STAT & PH STAT.pptxALPHA STAT & PH STAT.pptx
ALPHA STAT & PH STAT.pptx
 
Cardioplegia
CardioplegiaCardioplegia
Cardioplegia
 
CPB during pregnancy and Anesthesia considration by Arsalan
CPB during pregnancy and Anesthesia considration by ArsalanCPB during pregnancy and Anesthesia considration by Arsalan
CPB during pregnancy and Anesthesia considration by Arsalan
 
Cardiopulmonary bypass effect to others organs
Cardiopulmonary bypass effect to others organsCardiopulmonary bypass effect to others organs
Cardiopulmonary bypass effect to others organs
 
Hypothermia and dhca
Hypothermia and dhcaHypothermia and dhca
Hypothermia and dhca
 
MICS
MICSMICS
MICS
 
Myocardial Protection in Pediatric Cardiac Surgery
Myocardial Protection in Pediatric Cardiac SurgeryMyocardial Protection in Pediatric Cardiac Surgery
Myocardial Protection in Pediatric Cardiac Surgery
 
Priming fluid and hemodilution
Priming fluid and hemodilutionPriming fluid and hemodilution
Priming fluid and hemodilution
 
cannulation techniques during cpb
cannulation techniques during cpbcannulation techniques during cpb
cannulation techniques during cpb
 
Immune system and inflamatory response to cpb(1)
Immune system and inflamatory response to cpb(1)Immune system and inflamatory response to cpb(1)
Immune system and inflamatory response to cpb(1)
 
Cardiopulmonary bypass
Cardiopulmonary bypassCardiopulmonary bypass
Cardiopulmonary bypass
 

Similar to Myocardial protection DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB CTS SR

Paediatric Myocaedial protection
Paediatric Myocaedial protectionPaediatric Myocaedial protection
Paediatric Myocaedial protection
India CTVS
 
Cardio-Pulmonary Bypass: A Brief Overview
Cardio-Pulmonary Bypass: A Brief OverviewCardio-Pulmonary Bypass: A Brief Overview
Cardio-Pulmonary Bypass: A Brief Overview
AlanSeikka1
 
Etiopathogenesis of stroke
Etiopathogenesis of strokeEtiopathogenesis of stroke
Etiopathogenesis of stroke
Dr Naresh Kancha
 
SHOCK.pptx
SHOCK.pptxSHOCK.pptx
SHOCK.pptx
Dr.MD Hakim
 
cerebral ischemia and infarction.pptx
cerebral ischemia and infarction.pptxcerebral ischemia and infarction.pptx
cerebral ischemia and infarction.pptx
vinay nandimalla
 
Basic principles of cardioplegia
Basic principles of cardioplegiaBasic principles of cardioplegia
Basic principles of cardioplegia
Jai Ganesh
 
Pathophysiology of acute kidney injury
Pathophysiology of acute kidney injuryPathophysiology of acute kidney injury
Pathophysiology of acute kidney injury
Snehasis Ghosh
 
Vasoplegic shock
Vasoplegic shockVasoplegic shock
Vasoplegic shock
Vaibhav Mahankale
 
local control of blood flow.pptx
local control of blood flow.pptxlocal control of blood flow.pptx
local control of blood flow.pptx
JoshuaNanlir
 
SHOCK.pptx
SHOCK.pptxSHOCK.pptx
SHOCK.pptx
KalaivaniGanapathy
 
Cerebral edema and its management
Cerebral edema and its managementCerebral edema and its management
Cerebral edema and its management
Rajesh Kabilan
 
Cad
CadCad
Cardiogenic shock - Anesthesiology and ICU
Cardiogenic shock - Anesthesiology and ICUCardiogenic shock - Anesthesiology and ICU
Cardiogenic shock - Anesthesiology and ICU
Ishfak Maisoor
 
CEREBRAL EDEMA.pptx
CEREBRAL EDEMA.pptxCEREBRAL EDEMA.pptx
CEREBRAL EDEMA.pptx
PragyanParamitaSatap
 
Coronary artery diseases
Coronary artery diseasesCoronary artery diseases
Coronary artery diseases
Denis Katatwire
 
Physiological basis of coronary revascularisation
Physiological basis of coronary revascularisationPhysiological basis of coronary revascularisation
Physiological basis of coronary revascularisation
Debajyoti Chakraborty
 
Progressive Shock
Progressive ShockProgressive Shock
Progressive Shock
Anshu Chandra
 
Shock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptxShock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptx
ssuser2b0ef3
 
Stroke 2021
Stroke     2021Stroke     2021
Stroke 2021
stewardmbewe
 

Similar to Myocardial protection DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB CTS SR (20)

Paediatric Myocaedial protection
Paediatric Myocaedial protectionPaediatric Myocaedial protection
Paediatric Myocaedial protection
 
Cardio-Pulmonary Bypass: A Brief Overview
Cardio-Pulmonary Bypass: A Brief OverviewCardio-Pulmonary Bypass: A Brief Overview
Cardio-Pulmonary Bypass: A Brief Overview
 
Etiopathogenesis of stroke
Etiopathogenesis of strokeEtiopathogenesis of stroke
Etiopathogenesis of stroke
 
SHOCK.pptx
SHOCK.pptxSHOCK.pptx
SHOCK.pptx
 
cerebral ischemia and infarction.pptx
cerebral ischemia and infarction.pptxcerebral ischemia and infarction.pptx
cerebral ischemia and infarction.pptx
 
Basic principles of cardioplegia
Basic principles of cardioplegiaBasic principles of cardioplegia
Basic principles of cardioplegia
 
Pathophysiology of acute kidney injury
Pathophysiology of acute kidney injuryPathophysiology of acute kidney injury
Pathophysiology of acute kidney injury
 
Vasoplegic shock
Vasoplegic shockVasoplegic shock
Vasoplegic shock
 
local control of blood flow.pptx
local control of blood flow.pptxlocal control of blood flow.pptx
local control of blood flow.pptx
 
SHOCK.pptx
SHOCK.pptxSHOCK.pptx
SHOCK.pptx
 
Cerebral edema and its management
Cerebral edema and its managementCerebral edema and its management
Cerebral edema and its management
 
Cad
CadCad
Cad
 
Cardiogenic shock - Anesthesiology and ICU
Cardiogenic shock - Anesthesiology and ICUCardiogenic shock - Anesthesiology and ICU
Cardiogenic shock - Anesthesiology and ICU
 
CEREBRAL EDEMA.pptx
CEREBRAL EDEMA.pptxCEREBRAL EDEMA.pptx
CEREBRAL EDEMA.pptx
 
Coronary artery diseases
Coronary artery diseasesCoronary artery diseases
Coronary artery diseases
 
Physiological basis of coronary revascularisation
Physiological basis of coronary revascularisationPhysiological basis of coronary revascularisation
Physiological basis of coronary revascularisation
 
Progressive Shock
Progressive ShockProgressive Shock
Progressive Shock
 
Shock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptxShock (intensive course 1st year Mmed).pptx
Shock (intensive course 1st year Mmed).pptx
 
Progressive Shock
Progressive ShockProgressive Shock
Progressive Shock
 
Stroke 2021
Stroke     2021Stroke     2021
Stroke 2021
 

More from DR NIKUNJ SHEKHADA

Aortic repair ppt
Aortic repair pptAortic repair ppt
Aortic repair ppt
DR NIKUNJ SHEKHADA
 
Aortic valve disease
Aortic valve diseaseAortic valve disease
Aortic valve disease
DR NIKUNJ SHEKHADA
 
Mitral valve surgical treatment
Mitral valve surgical treatmentMitral valve surgical treatment
Mitral valve surgical treatment
DR NIKUNJ SHEKHADA
 
Mitral valve repair
Mitral valve repairMitral valve repair
Mitral valve repair
DR NIKUNJ SHEKHADA
 
Mitral valve disease
Mitral valve diseaseMitral valve disease
Mitral valve disease
DR NIKUNJ SHEKHADA
 
Aortic valve disease
Aortic valve diseaseAortic valve disease
Aortic valve disease
DR NIKUNJ SHEKHADA
 
Aortic repair ppt
Aortic repair pptAortic repair ppt
Aortic repair ppt
DR NIKUNJ SHEKHADA
 
Surgical emphsema
Surgical emphsemaSurgical emphsema
Surgical emphsema
DR NIKUNJ SHEKHADA
 
Cardiac cycle DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Cardiac cycle DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Cardiac cycle DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Cardiac cycle DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
History of cardiac surgery DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
History of cardiac surgery  DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)History of cardiac surgery  DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
History of cardiac surgery DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
Cpb oxygenators DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Cpb oxygenators  DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Cpb oxygenators  DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Cpb oxygenators DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
Chordal preservation DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Chordal preservation DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Chordal preservation DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Chordal preservation DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
Anatomy tricuspid valve DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Anatomy tricuspid valve DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Anatomy tricuspid valve DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Anatomy tricuspid valve DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
Post oprative care 1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Post oprative care 1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)Post oprative care 1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Post oprative care 1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
Ecg1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Ecg1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)Ecg1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Ecg1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
Aortic root anatomy DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Aortic root anatomy DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)Aortic root anatomy DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Aortic root anatomy DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
CARDIO PLEGIA DELIVERY DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
CARDIO PLEGIA DELIVERY  DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRCARDIO PLEGIA DELIVERY  DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
CARDIO PLEGIA DELIVERY DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
DR NIKUNJ SHEKHADA
 
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRAtrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
DR NIKUNJ SHEKHADA
 
Asd managment DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Asd managment DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)Asd managment DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Asd managment DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
DR NIKUNJ SHEKHADA
 
Mitral valve surgical anatomy DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB C...
Mitral valve surgical anatomy DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB C...Mitral valve surgical anatomy DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB C...
Mitral valve surgical anatomy DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB C...
DR NIKUNJ SHEKHADA
 

More from DR NIKUNJ SHEKHADA (20)

Aortic repair ppt
Aortic repair pptAortic repair ppt
Aortic repair ppt
 
Aortic valve disease
Aortic valve diseaseAortic valve disease
Aortic valve disease
 
Mitral valve surgical treatment
Mitral valve surgical treatmentMitral valve surgical treatment
Mitral valve surgical treatment
 
Mitral valve repair
Mitral valve repairMitral valve repair
Mitral valve repair
 
Mitral valve disease
Mitral valve diseaseMitral valve disease
Mitral valve disease
 
Aortic valve disease
Aortic valve diseaseAortic valve disease
Aortic valve disease
 
Aortic repair ppt
Aortic repair pptAortic repair ppt
Aortic repair ppt
 
Surgical emphsema
Surgical emphsemaSurgical emphsema
Surgical emphsema
 
Cardiac cycle DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Cardiac cycle DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Cardiac cycle DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Cardiac cycle DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
 
History of cardiac surgery DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
History of cardiac surgery  DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)History of cardiac surgery  DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
History of cardiac surgery DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
 
Cpb oxygenators DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Cpb oxygenators  DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Cpb oxygenators  DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Cpb oxygenators DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
 
Chordal preservation DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Chordal preservation DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Chordal preservation DR  NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Chordal preservation DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
 
Anatomy tricuspid valve DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Anatomy tricuspid valve DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)Anatomy tricuspid valve DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
Anatomy tricuspid valve DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG ,DNB CTS SR)
 
Post oprative care 1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Post oprative care 1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)Post oprative care 1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Post oprative care 1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
 
Ecg1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Ecg1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)Ecg1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Ecg1 DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
 
Aortic root anatomy DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Aortic root anatomy DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)Aortic root anatomy DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Aortic root anatomy DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
 
CARDIO PLEGIA DELIVERY DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
CARDIO PLEGIA DELIVERY  DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRCARDIO PLEGIA DELIVERY  DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
CARDIO PLEGIA DELIVERY DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
 
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SRAtrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
Atrial septal defect DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR
 
Asd managment DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Asd managment DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)Asd managment DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
Asd managment DR NIKUNJ R SHEKHADA (MBBS,MS GEN SURG,DNB CTS SR)
 
Mitral valve surgical anatomy DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB C...
Mitral valve surgical anatomy DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB C...Mitral valve surgical anatomy DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB C...
Mitral valve surgical anatomy DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB C...
 

Recently uploaded

Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
DrSathishMS1
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 

Recently uploaded (20)

Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
THOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation ActTHOA 2.ppt Human Organ Transplantation Act
THOA 2.ppt Human Organ Transplantation Act
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 

Myocardial protection DR NIKUNJ R SHEKHADA (MBBS ,MS GRN SURG , DNB CTS SR

  • 1. MYOCARDIAL PROTECTION BY DR NIKUNJ (CTS RESIDENT STAR HOSPITAL) (Coordinator:DR P.SATYENDRANATH PATHURI) (22/10/18)
  • 2. HISTORICAL DEVELOPMENT • After the initiation of open heart surgery with use of extra- corporeal circulation by Gibbon, it soon became obvious that aortic cross-clamping was necessary to provide a bloodless field to facilitate the precise repair of intracardiac defects, to prevent air embolism when the left side of the heart was opened, and to avoid a turgid myocardium resistant to retraction. • To overcome the difficulties of operating on a rheumatic mitral valve in a patient with aortic regurgitation, Melrose and colleagues introduced the concept of “elective cardiac arrest” by rapidly injecting into the aortic root, after aortic cross- clamping, a 2.5% potassium citrate solution in warm blood to arrest the heart. • myocardial necrosis associated with the Melrose technique.
  • 3. MYOCARDIAL PROTECTION • Involves strategies and methods used to reduce or prevent post-ischemic myocardial dysfunction during and after heart surgery.
  • 4. NON-CARDIOPLEGIC TECHNIQUES FIBRILLATORY ARREST • Electrically induced ventricular brillation with coronary perfusion was introduced by Glenn and Sewell and Senning as a means of avoiding air embolism. • subendocardial ischemia and necrosis with this technique. • Not applicable for intracardiac procedures • Field may be obscured by blood during revascularization • Ventricular fibrillation is associated with increased muscular tone (can limit surgeon’s ability to position the heart for optimal exposure)
  • 5. CONTINUOUS CORONARY PERFUSION • In an attempt to mimic the physiologic state, continuous coronary perfusion with a beating heart at normothermia or mild hypothermia at 32°C to prevent the onset of ventricular fibrillation became the preferred technique of myocardial preservation in the late 1960s and early 1970s, • particularly after the report by McGoon and colleagues17 of 100 consecutive aortic valve replacements with no deaths. • continuous perfusion became intermittent as coronary perfusion was often discontinued to achieve better visualization of the operative field during critical portions of the procedure. • In addition, problems with the coronary cannula, such as poor fixation, leaking associated with calcified ostia, early division of the left main coronary artery resulting in high perfusion pressure necrosis, and damage to the coronary artery such as dissection and late stenosis, continued to occur.
  • 6. HYPOTHERMIA • The earliest attempts to perform open heart surgery before the advent of the heart- lung machine used systemic hypothermia produced by surface cooling not only to protect the heart but to protect the brain and other organs during circulatory arrest • Hypothermia protects the ischemic myocardium by decreasing heart rate, slows the rate of high-energy phosphate degradation,24 and decreases myocardial oxygen consumption . • concept of profound local (topical) hypothermia by filling the pericardial sac with ice- cold saline. • this technique is still used as an adjunct to other methods of myocardial protection, it is rarely used as the sole protec- tive method because of the problem of warm bronchia collateral flow reaching the heart cavity, resulting in transmyocardial temperature gradients and resultant ischemia. •
  • 7. • Hypothermia and potassium infusions remain cornerstone of myocardial protection during on- pump heart surgery • Other cardioprotective techniques and methods are available. • • Ideal cardioprotective technique, solution, and method of administration have yet to be found
  • 8. BIOLOGY OF SURGICALLY INDUCED MYOCARDIAL ISCHEMIA • Myocardial Oxygen Consumption : • Myocardial oxygen reserve is exhausted within 8 seconds after the onset of normothermic global ischemia. • Myocardial oxygen consumption ( MVO2) is compartmentalized into the oxygen needed for external work of contraction (80% to 90%) and the unloaded contraction, such as basal metabolism, excitation-contraction coupling, and heat production. • A unique aspect of myocardial energetics is that 75% of the coronary arterial oxygen presented to the myocardium is extracted during a single passage through the heart;
  • 9. BIOLOGY OF SURGICALLY INDUCED MYOCARDIAL ISCHEMIA • Biochemical Alterations: • Under aerobic conditions, the heart derives its energy primarily from mitochondrial oxidative processes, using substrates such as glucose, free fatty acids, lactate, pyruvate, acetate, ketone bodies, and amino acids. However, oxidation of fatty acids provides the major source of energy production and is used in preference to carbohydrates. • as tissue PO2 falls, oxidative phosphorylation, electron transport, and mitochondrial adenosine triphosphate (ATP) production cease. • Reduced mitochondrial activity leads to the accumulation of glycolytic intermediaries, reduced NADH, and the reduction of pyruvate to lactate. The resultant severe intracellular acidosis impairs contractile function, enzyme transport, and cell membrane integrity. • This results in a cellular loss of potassium and pathologic accumulation of sodium, calcium, and water
  • 10.
  • 12. CALCIUM HYPOTHESIS • Inability of myocyte to modulate intracellular and intraorganellar calcium homeostasis. • • Cascade of events culminating in cell injury and death is induced . • Calcium. • if given as patients come off of bypass, it can lead to contracture of heart (maximally contracted heart) • Therefore, it is desirable to avoid calcium when heart is recovering from arrest
  • 13.
  • 14. FREE RADICAL HYPOTHESIS • Accumulation of reactive oxygen species (ROS) – during early stages of reperfusion – causes myocardial cellular damage and cell death through microscomal peroxidation of cellular phospholipid layer • Leads to loss of cellular integrity and function
  • 15. • Stunning: “describes the mechanical dysfunction that persists after reperfusion despite the absence of myocellular damage and despite the return of normal or nearnormal perfusion.” • Hibernation:, which is a syndrome of reversible, chronically reduced contractile function as a result of one or more recurrent episodes of acute or persistent ischemia, referred to as chronic stunning
  • 16. IRREVERSIBLE CELL INJURY • necrosis and apoptosis. • Necrosis is initiated by noncellular mechanisms with cell swelling, depletion of ATP stores, and disruption of the cellular membrane involving uid and electrolyte alterations. • In contrast, apoptosis (programmed cell death) is an evolution-based mode of cell death characterized by a discrete set of biochemical and morphologic events involving the regulated action of catabolic enzymes (proteases and nucleases) that results in the ordered disassembly of the cell, distinct from cell death provoked by external injury.
  • 17. ISCHEMIA-REPERFUSION INJURY • INFLAMMATION • In ammation has been implicated as a secondary mecha- nism contributing to injury after reperfusion. It is initi- ated through complement activation leading to the sequential formation of a membrane attack complex, which creates a cellular lesion and eventual cell lysis. • EFFECTS OF AGE • The vulnerability of the heart to ischemia-reperfusion injury is altered with temporal development. The newborn heart is more resistant to the effects of ischemia- reperfusion. • in the adult heart, functional recovery is significantly delayed • CYANOSIS • Cyanosis signi cantly increases the vulnerability of the myocardium to ischemia- reperfusion injury. • VENTRICULAR HYPERTROPHY • Hypertrophied hearts have an increased vulnerability to ischemic injury
  • 18. • All patients undergoing cardiac surgery have varying degrees of myocardial stunning • Evidence: • Requirement of inotropic support for separation from bypass • Support may last from hours to days after surgery • Patients are eventually weaned from these drugs as the stunning abates, without objective evidence of MI
  • 19. CARDIOPLEGIA: BASIC PRINCIPLES • (1) rapid induction of arrest, • (2) mild or moderate hypothermia, • (3) appropriate buffering of the cardioplegic solution, • (4) avoidance of myocardial edema, and • (5) avoidance of substrate depletion.
  • 20. (1) RAPID INDUCTION OF ARREST • Rapid cardiac arrest remains the mainstay of adequate myocardial protection and is “achieved by targeting various points in the excitation-contraction coupling pathway”
  • 21. DEPOLARIZED ARREST • Potassium is the most common agent used for chemical cardioplegia and produces rapid diastolic arrest. • As the extracellular potassium concentration increases, the resting myocardial cell membrane becomes depolarized; the voltage-dependent fast sodium channel is inactivated, arresting the heart in diastole; and the slow calcium channel is activated, resulting in cytosolic calcium overload • The optimum concentration of potassium is thought to vary between 15 and 40 mmol/liter although it has been suggested that concentrations exceeding 20 mmol/liter promote calcium overload and subsequent injury. • Because the heart will remain arrested until the concentration of extracellular potassium or other cardioplegic ingredient is decreased by noncoronary collateral mediastinal blood flow, reinfusions of cardioplegia are necessary every 15 to 30 minutes •
  • 22.
  • 23. POLARIZED ARREST • Agents inducing polarized arrest, in which the cell membrane potential remains close to resting potential, have significant advantages by limiting ionic movement and thereby reducing myocardial energy use • Sodium channel blockade, which arrests the heart by preventing the rapid sodium- induced depolarization of the action potential, includes procaine and tetrodotoxin. This class of drugs has been used successfully experimentally but is rarely used clinically at present.
  • 24. • Potassium channel openers induce arrest by membrane hyperpolarization, couple the membrane potential to the cellular metabolic status, and afford cardioprotection by a similar mechanism associated with ischemic preconditioning. • their clinical use remains controversial.
  • 25. • Adenosine is an endogenous nucleoside • Extracellular adenosine is cleared through cellular uptake, primarily by erythrocytes and vascular endothelial cells, and has a reported half-life of less than 10 seconds in whole blood, which limits its use during a prolonged period of surgically induced ischemia. • Adenosine induces hyperpolarized cardiac arrest by antagonizing calcium channels and has been shown to inhibit both the sinoatrial and the atrioventricular nodes and atrial myocardial contraction. • Adenosine, by its ability to antagonize the direct depressant effects on both the sinoatrial and atrioventricular nodes and atrial tissue, results in sinus slowing and arrest.
  • 26. HYPOTHERMIA • Hypothermia, whether it is mild (tepid at the room temperature range of 28° C to 32° C) or moderate (22° C to 25°C), continues to remain an indispensable adjunct for adequate myocardial protection. • hypothermia decreases the rate of the metabolic degradation of energy stores during surgically induced ischemia. • However, there is minimal advantage in reducing the myocardial temperature below 22° C, because the MVO2 is decreased by only a minimal amount, from 0.31 mL at 22°C to 0.27 mL at 15°C per 100 g of left ventricular tissue per minute
  • 27. BUFFERING OF THE CARDIOPLEGIC SOLUTION • Buffering of the cardioplegic solution is necessary to combat the unremitting intracellular acidosis associated with surgically induced myocardial ischemia. • Because the myocardium has the highest oxygen use of any organ in the body related to its concentration of mitochondria, ischemia results in the rapid accumulation of hydrogen ions and the reduction of intracellular pH • here is clinical evidence that maintenance of the tissue pH of 6.8 or greater is associated with adequate myocardial protection • In addition, hypothermia assists in the neutralization of acidosis because pH rises 0.0134 unit for each decrease in degree centigrade. • Bicarbonate, phosphate, aminosulfonic acid, tris(hydroxymethyl)aminomethane (THAM), and histidine buffers have all been used as cardioplegia additives to modulate pH.
  • 28. AVOIDANCE OF MYOCARDIAL EDEMA • Avoidance of myocardial edema by controlling osmolarity is important to control volume regulation of the fluid compartments of the heart because myocardial edema is a known consequence of ischemia. • The extent of myocardial edema has been shown to be directly modulated by osmolarity and onconicity of cardioplegia, with decreases being directly associated with increased myocardial edema and impaired diastolic filling. • The extent of myocardial edema has been shown to be directly modulated by osmolarity and onconicity of cardioplegia, with decreases being directly associated with increased myocardial edema and impaired diastolic filling. • In addition to cardioplegic infusions, the hemodilution from crystalloid priming of the extracorporeal circuit, the activation of humoral and cellular mediators that increase microvascular permeability, and the impairment of myocardial lymphatic function may play major roles in the development of myocardial edema. • Myocardial lymphatic function is dependent on the beating heart to transport fluid and is significantly reduced or completely stopped during cardiac arrest.
  • 29. CRYSTALLOID CARDIOPLEGIA • With the advent of myocardial protection, asanguineous solutions composed of varying electrolyte compositions, but always featuring hyperkalemic diastolic arrest, were clinically used in Europe in the early 1970s and in the United States in the late 1970s. • However, these solutions contained minimal amounts of dissolved oxygen, whereas the myocardium consumes 0.33 mL of oxygen per 100 g at 15° C. Because even a short period of ischemia results in the gradual accumulation of oxygen debt, moderate to severe myocardial hypothermia is necessary to prevent the rapid degradation of energy stores
  • 30. CRYSTALLOID CARDIOPLEGIA • Patients are first placed on CPB • Cooled to between 28-33 °C • Soln infused after cross-clamping aorta through cardioplegic catheter inserted into aorta proximal to cross-clamp
  • 31. BLOOD CARDIOPLEGIA • In an attempt to avoid the oxygen deficits associated with crystalloid cardioplegia, blood was introduced as a Suitable vehicle to obtain optimum oxygenation. • Experimentally, blood cardioplegia has been demonstrated to be superior to oxygenated crystalloid cardioplegia. • the physiologic advantages of blood include the buffering and reducing capacity, the presence of colloid to avoid adverse oncotic pressure gradients, and the presence of oxygen free radical scavengers • The early blood cardioplegia solutions used a ratio of four parts blood to one part crystalloid (4 : 1) • Del Nido cardioplegia techniques The cardioplegia solution is administered as a single dose, using dilute blood in a 1 : 4 ratio,
  • 32. METHODOLOGIES warm blood cardioplegia • Warm heart surgery assumes that aerobic arrest, whereby the heart is electromechanically arrested and continuously perfused with warm blood cardioplegia, is the ideal statefor the performance of safe cardiac surgery. • ADVANTAGES of this technique include • the presumed elimination of anaerobic ischemic injury with cross-clamp times safely extended up to 6.5 hours; • the early resumption of a normal sinus rhythm after removal of the aortic clamp; • the avoidance of a prolonged rewarming and reperfusion time, thus decreasing total bypass time; and the elimination of systemic hypothermia and associated vasoconstriction in the early postoperative period. • PROBLEMS : • However, difficulties in visualization of the operative field, particularly in performing distal coronary anastomoses, mandated temporary discontinuation of the warm cardioplegic infusion,
  • 33. COLD BLOOD CARDIOPLEGIA • Prepared by combining autologous blood from extracorporeal circuit (while patient is on CPB) with a crystalloid soln of: • citrate-phosphate-dextrose (CPD)  lowers ionic calcium • tris-hydroxymethyl-aminomethane (tham) or bicarbonate buffersmaintains alkaline pH of ~7.8 • potassium chloride  arrests heart at 30 mmol/L • pH = 7.4 is physiologic, but pH is temp dependent, and optimal buffering occurs when pKa is 7.8.
  • 34. COLD BLOOD CARDIOPLEGIA • Reasons to use blood for hypothermic potassium-induced cardiac arrest: • Provides oxygenated environment • Provides method for intermittent reoxygenation of heart during arrest • Can limit hemodilution when large volumes of cardioplegia are used • Has excellent buffering capacity • Has excellent osmotic properties • The electrolyte composition and pH are physiologic • Contains endogenous antioxidants and free-radical scavengers • Is less complex than other solns to prepare
  • 35. TEPID (29°C) CARDIOPLEGIA • introduced as a means of overcoming the deficits of warm cardioplegia, without the adverse effects of cold cardioplegia. • Both cold blood and warm blood solns have temperature related advantages and disadvantages
  • 36. METHODS OF DELIVERY • Methods of Delivery ; • INTERMITTENT ANTEGRADE • ANTEGRADE VIA THE CORONARY BYPASS GRAFTS • CONTINUOUS ANTEGRADE • CONTINUOUS RETROGRADE • INTERMITTENT RETROGRADE • ANTEGRADE FOLLOWED BY RETROGRADE • SIMULTANEOUS ANTEGRADE AND RETROGRADE
  • 37. RETROGRADE PERFUSION • 1965 – Lillehei et al. Dis Chest. • Reported use of retrograde perfusion to protect heart during aortic valve surgery • ADVANTAGE of ensuring a more homogeneous distribution of cardioplegic soln to regions of heart that are poorly collateralized • Effective in setting of AR and valve surgery • Effective in reducing risk of embolization from SVGs that could occur during antegrade perfusion during re-op CABG • Effective in delivering cardioplegia in continuous manner • LIMITATIONS: • Soln can be poorly distributed to the right ventricle due to the variable venous anatomy of the heart • Best and most continuous perfusion of the anterior left and right ventricles is achieved using antegrade and retrograde routes simultaneously

Editor's Notes

  1. However, Buckberg and Hottenrott12 and Hottenrott and cowork- ers13 demonstrated subendocardial ischemia and necrosis with this technique,